Stay updated on Idasanutlin Combo Therapy in AML Clinical Trial

Sign up to get notified when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Idasanutlin Combo Therapy in AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The clinical trial record for idasanutlin in newly diagnosed AML is displayed, with study design, eligibility, locations, outcome measures, and record documents. It reports that the trial was terminated after Phase 1 and that the planned Phase 2 was not initiated.
    Difference
    97%
    Check dated 2026-11-08T13:28:26.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T14:54:08.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology across its content.
    Difference
    1%
    Check dated 2026-10-25T13:44:03.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:22:58.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T13:56:13.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page instead of the study content, with boilerplate HTML and a 403 title, indicating an access issue when attempting to view the study entry.
    Difference
    0.5%
    Check dated 2026-09-27T19:43:39.000Z thumbnail image

Stay in the know with updates to Idasanutlin Combo Therapy in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.